IART Q3 2025 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$402M+5.6% YoY

Gross Profit

$226M56.2% margin

Operating Income

$40M10.0% margin

Net Income

-$5M-1.3% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

-3.3%

Cash Flow

Operating Cash Flow

$41M

Free Cash Flow

$26M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$3.6B

Total Liabilities

$2.6B

Stockholders' Equity

$1.0B

Cash & Equivalents

$232M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$402M	$381M	+5.6%
Gross Profit	$226M	$200M	+12.9%
Operating Income	$40M	-$8M	+594.4%
Net Income	-$5M	-$11M	+49.5%

Revenue Segments

Codman Specialty Surgical

$293M73%

Tissue Technologies

$109M27%

Geographic Segments

UNITED STATES

$296M74%

Europe

$43M11%

Asia Pacific

$43M11%

Rest Of The World

$21M5%